📢 TEC Inaugural Members Summit | November 5–6, 2026 | ZEISS Innovation Center, Dublin, California | Attendance by Invitation Only
📢 TEC Inaugural Members Summit | November 5–6, 2026 | ZEISS Innovation Center, Dublin, California | Attendance by Invitation Only
Zyloware–Kenmark
Vera Wang
Lilly Pulitzer
Original Penguin
Kensie
Paradigm
Elliott Ives
Jhane Barnes
Stetson
Via Spiga
Want to identify AMD risk earlier? Visible Genomics helps eye care professionals add genetic insight to AMD care with AMDiGuard™, a CLIA-certified genetic test designed to identify genetic markers associated with AMD risk and progression.
AMDiGuard adds a genetic layer to family history and clinical findings, helping providers identify higher-risk patients earlier and support more informed monitoring, counseling, and preventive care conversations.
Identify AMD Risk Before Vision Loss. Add Genetic Insight to AMD Care.
More than 20 million Americans are living with age-related macular degeneration (AMD), and genetics play an important role in AMD risk.
Visible Genomics helps eye care professionals bring genetic insight into AMD care with AMDiGuard™, a CLIA-certified cheek-swab genetic test designed to identify genetic markers associated with AMD risk and progression.
AMDiGuard adds genetic information to the clinical picture alongside family history and exam findings, helping providers identify patients with higher genetic risk and support more informed conversations around monitoring, lifestyle, and preventive care.
Designed for real-world eye care practices, AMDiGuard requires no blood draw, can fit into a routine patient visit, and provides results in a HIPAA-compliant format.
What’s Included with AMDiGuard?
Preferred Access for TEC Members
TEC members can receive preferred access to AMDiGuard resources and support when exploring genetic AMD risk testing for their practice.
Member Benefits
Preferred Pricing
Access volume-tiered pricing on AMDiGuard testing kits designed to accommodate practices of different sizes.
Complimentary Training Materials
Receive front-office and clinical staff training resources to help your team understand the testing process.
Priority Onboarding Support
Get assistance as your practice begins incorporating AMDiGuard into its workflow.
Dedicated Customer Support
Have access to ongoing support as your team uses AMDiGuard.
No Commitment to Get Started
Explore how genetic risk testing may fit into your practice before making a larger commitment.
Interested in AMDiGuard?
Tell us about your practice and connect with Visible Genomics to learn more about member pricing, sample kits, and training resources.
Simple. Predictive. Actionable.
Visible Genomics helps eye care professionals incorporate DNA-based AMD insight into everyday practice in a way that is designed to be clinically relevant, easy to implement, and useful for patient conversations.
Clinically Grounded
AMDiGuard evaluates genetic markers associated with AMD risk and progression, giving providers another source of information to consider alongside established clinical findings.
Practice-Ready
A simple buccal cheek swab makes sample collection easy to incorporate into routine visits without requiring a blood draw.
Comprehensive Risk Insight
Genetic information can be considered alongside family history and clinical findings, providing a more complete picture of an individual patient’s AMD risk.
Patient-Focused
Genetic risk information can help create more meaningful conversations with patients about their individual risk, monitoring, lifestyle, and preventive care.
Designed for Everyday Eye Care
AMDiGuard is built to fit into existing optometry and ophthalmology workflows without adding unnecessary complexity to the patient experience.
AMDiGuard™ Genetic Testing
Add a Genetic Layer to AMD Care
AMDiGuard is designed to help eye care professionals identify genetic markers associated with AMD risk and progression.
The testing solution combines genetic analysis with practical resources that help practices incorporate genetic risk assessment into their existing patient care process.
AMDiGuard DNA Risk Test
Helps identify genetic markers associated with AMD risk, providing additional information that can be considered alongside family history and clinical findings.
AMDiGuard DNA Progression Test
Provides genetic information related to AMD progression risk to support a more individualized approach to patient monitoring and care conversations.
CFH & ARMS2 Analysis
AMDiGuard includes analysis of genetic markers including CFH and ARMS2, which are associated with AMD genetic risk.
Simple Buccal Collection
The patient provides a cheek-swab sample, eliminating the need for a blood draw and making collection straightforward for the practice.
Patient Education Resources
Risk-factor checklists and educational materials help providers explain AMD risk and make genetic testing easier for patients to understand.
Practice Training & Support
Visible Genomics provides clinical and front-office resources designed to help practices understand the testing process and incorporate it into their workflow.
Zyloware–Kenmark makes it easier for practices to create a diverse and patient-focused optical assortment.
1. Explore the Portfolio
Discover collections across fashion, lifestyle, heritage, everyday, and fit-focused categories.
2. Identify Your Patient Needs
Consider the styles, fits, materials, price points, and brands that best match your patient base.
3. Build Your Selection
Choose collections and frames that complement your existing optical inventory and create greater variety.
4. Give Patients More Choice
Offer patients more opportunities to find eyewear that matches their face, lifestyle, personality, and budget.
5. Grow Your Optical
A well-rounded frame assortment can help create a more engaging optical experience and give your team more options when recommending eyewear.
A Partnership Built on Earlier, Clearer Answers
The partnership between Visible Genomics, AMDiGuard, and The Eye Consortium helps independent eyecare practices integrate DNA-based AMD testing into everyday patient care.
TEC members can access genetic risk and progression information that may complement traditional clinical assessment and support more personalized monitoring and patient counseling.
What This Partnership Brings
Earlier Genetic Insight
Add genetic information to family history and clinical findings when assessing AMD risk.
Simple Implementation
A straightforward cheek-swab collection process is designed to fit into routine practice workflows.
Patient Education Support
Use educational resources and risk-factor checklists to help patients better understand their AMD risk.
Practice Training
Access materials designed to support both clinical and front-office staff.
Member Support
Receive onboarding assistance and ongoing support as your practice incorporates AMDiGuard.
Personalized Patient Conversations
Use genetic risk information as an additional tool when discussing monitoring, lifestyle, and preventive care.
Designed for Independent Eyecare
Visible Genomics and TEC share a focus on helping independent practices access practical tools that can be incorporated into everyday patient care.
